Every successful sterile pharmaceutical facility starts with one decision: build quality into the design, not after the inspection.

EU GMP Annex 1 has changed how the industry approaches contamination control, cleanroom design, validation, and sterile manufacturing. While many see it as a European guideline, its principles are shaping pharmaceutical projects around the world—including India.

The most expensive compliance issues usually aren't discovered in documentation—they're built into the facility itself. Poor layouts, ineffective HVAC zoning, and weak contamination control strategies can lead to delays, costly modifications, and difficult regulatory inspections.

That's why smart pharmaceutical companies are investing in compliance from Day One.

At QxP Pharma Project Consultant & GMP Services, we help manufacturers transform GMP requirements into practical, inspection-ready facilities through turnkey project consulting, cleanroom engineering, validation, and regulatory compliance support.

Because the best time to prepare for an inspection is long before it happens.